TRP_1170x120_12-19-19

Zantac

Sanofi recalls Zantac in the U.S. and Canada

Sanofi recalls Zantac in the U.S. and Canada

BRIDGEWATER, N.J.— Sanofi announced on Friday that it was recalling the over-the-counter heartburn drug Zantac in the United States and Canada, a month after the Food and Drug Administration first alerted the public that versions of the drug contained low levels of a cancer-causing contaminant. Several manufacturers of generic versions of Zantac, ranitidine, had already recalled their

Lewis Drug removes all forms of Zantac from shelves

Lewis Drug removes all forms of Zantac from shelves

SIOUX FALLS, S.D. — Lewis Drug stores has joined the growing list of drug chains removing all forms of Zantac from store shelves. This includes brand name and generic products, including their private label Premier Value ranitidine products. Some ranitidine products were found to contain low levels of an impurity called N-nitrosodimethylamine (NDMA). “Not all

CVS halts sales of Zantac, other ranitidine products

CVS halts sales of Zantac, other ranitidine products

WOONSOCKET, R.I. — CVS Pharmacy has suspended the sale of all Zantac brand and CVS Health brand ranitidine products until further notice. This action is being taken out of an abundance of caution due to a recent Product Alert from the U.S. Food and Drug Administration (FDA) that ranitidine products may contain a low level